Detalles de la búsqueda
1.
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials.
Ann Oncol
; 27(6): 1068-1074, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27045102
2.
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment.
Ann Oncol
; 26(4): 731-736, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25628445
3.
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial.
Br J Cancer
; 110(5): 1148-54, 2014 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24407191
4.
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study.
ESMO Open
; 8(3): 101574, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244250
5.
Pravastatin may improve neurological outcome following low-grade aneurysmal subarachnoid hemorrhage.
J Clin Neurosci
; 98: 11-14, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131719
6.
Real-world first-line treatment of patients with BRAFV600E-mutant metastatic colorectal cancer: the CAPSTAN CRC study.
ESMO Open
; 7(6): 100603, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368253
7.
Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial.
ESMO Open
; 6(6): 100318, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34837745
8.
[Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?] / Radiothérapie stéréotaxique hépatique : particularités cliniques et implications techniques, résultats. Quelle machine pour quelle situation ?
Cancer Radiother
; 23(6-7): 636-650, 2019 Oct.
Artículo
en Francés
| MEDLINE | ID: mdl-31444078
9.
Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX.
Cancer Chemother Pharmacol
; 69(3): 807-14, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22037922
Resultados
1 -
9
de 9
1
Próxima >
>>